Cardiometabolic function in Offspring, Mother and Placenta after Assisted Reproductive Technology (COMPART): a prospective cohort study.

ABSTRACT:

Introduction

The Cardiometabolic function in Offspring, Mother and Placenta after Assisted Reproductive Technology (COMPART) study is a prospective cohort study aiming to explore health outcomes in mothers and children following assisted reproductive technology (ART), with a particular focus on frozen embryo transfer (FET) versus fresh embryo transfer (fresh-ET). The increasing prevalence of ART and FET emphasises the need to assess potential health risks associated with the procedures, both in pregnancy, such as pre-eclampsia and large for gestational age offspring, and in the children, such as obesity and cardiometabolic dysfunction.

Methods and analysis

The cohort will include 600 pregnant women, their potential partner and their offspring in a 1:1:1 ratio of pregnancies

SUBMITTER: Kjaer ASL 

PROVIDER: S-EPMC12443178 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature